SCIEGEN PHARMS INC FDA Approval ANDA 205237

ANDA 205237

SCIEGEN PHARMS INC

FDA Drug Application

Application #205237

Application Sponsors

ANDA 205237SCIEGEN PHARMS INC

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002
None (Tentative Approval)003
None (Tentative Approval)004

Application Products

001TABLET;ORAL50MG0LACOSAMIDELACOSAMIDE
002TABLET;ORAL100MG0LACOSAMIDELACOSAMIDE
003TABLET;ORAL150MG0LACOSAMIDELACOSAMIDE
004TABLET;ORAL200MG0LACOSAMIDELACOSAMIDE

FDA Submissions

UNKNOWN; ORIG1TA2020-09-21STANDARD

Submissions Property Types

ORIG1Null29

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB

CDER Filings

SCIEGEN PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 205237
            [companyName] => SCIEGEN PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LACOSAMIDE","activeIngredients":"LACOSAMIDE","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/21\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-09-21
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.